138 related articles for article (PubMed ID: 34857410)
1. Validation of epistaxis severity score for hereditary hemorrhagic telangiectasia in Japan.
Hayama M; Maeda Y; Shikina T; Tatehara S; Inokuchi G; Hoag JB; Sato T; Obata S; Nakatani A; Amano Y; Hida E; Nibu KI; Inohara H
Auris Nasus Larynx; 2022 Jun; 49(3):415-420. PubMed ID: 34857410
[TBL] [Abstract][Full Text] [Related]
2. The effects of epistaxis on health-related quality of life in patients with hereditary hemorrhagic telangiectasia.
Merlo CA; Yin LX; Hoag JB; Mitchell SE; Reh DD
Int Forum Allergy Rhinol; 2014 Nov; 4(11):921-5. PubMed ID: 25145809
[TBL] [Abstract][Full Text] [Related]
3. The minimal important difference of the epistaxis severity score in hereditary hemorrhagic telangiectasia.
Yin LX; Reh DD; Hoag JB; Mitchell SE; Mathai SC; Robinson GM; Merlo CA
Laryngoscope; 2016 May; 126(5):1029-32. PubMed ID: 26393959
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Timolol in a Novel Intranasal Thermosensitive Gel for Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis: A Randomized Clinical Trial.
Peterson AM; Lee JJ; Kallogjeri D; Schneider JS; Chakinala MM; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1006-1014. PubMed ID: 32940653
[TBL] [Abstract][Full Text] [Related]
5. Assessing the Psychometric Validity of the Epistaxis Severity Score: Internal Consistency and Test-Retest Reliability.
Gong AJ; Bolsegui ML; Lee EE; Mathai SC; Weiss CR
Am J Rhinol Allergy; 2024 Jan; 38(1):38-46. PubMed ID: 37822162
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of the Nasal Outcome Score for Epistaxis in Hereditary Hemorrhagic Telangiectasia (NOSE HHT).
Peterson AM; Kallogjeri D; Spitznagel E; Chakinala MM; Schneider JS; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):999-1005. PubMed ID: 33022056
[TBL] [Abstract][Full Text] [Related]
7. A new endoscopic staging system for hereditary hemorrhagic telangiectasia.
Reh DD; Yin LX; Laaeq K; Merlo CA
Int Forum Allergy Rhinol; 2014 Aug; 4(8):635-9. PubMed ID: 24782401
[TBL] [Abstract][Full Text] [Related]
8. FID Score: an effective tool in Hereditary Haemorrhagic Telangiectasia - related epistaxis.
Pagella F; Maiorano E; Matti E; Tinelli C; De Silvestri A; Ugolini S; Lizzio R; Olivieri C; Pusateri A; Spinozzi G
Rhinology; 2020 Oct; 58(5):516-521. PubMed ID: 32584331
[TBL] [Abstract][Full Text] [Related]
9. Randomized, controlled, double-blinded clinical trial of effect of bevacizumab injection in management of epistaxis in hereditary hemorrhagic telangiectasia patients undergoing surgical cauterization.
Khanwalkar AR; Rathor A; Read AK; Paknezhad H; Ma Y; Hwang PH
Int Forum Allergy Rhinol; 2022 Aug; 12(8):1034-1042. PubMed ID: 34989143
[TBL] [Abstract][Full Text] [Related]
10. Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT).
Lee JM; Wu V; Faughnan ME; Lasso A; Figol A; Kilty SJ
J Otolaryngol Head Neck Surg; 2019 Oct; 48(1):48. PubMed ID: 31615556
[TBL] [Abstract][Full Text] [Related]
11. Exploring effects of atmospheric conditions in hereditary hemorrhagic telangiectasia.
Yusuf HM; Rasheed A; Hetts S; Kim H; Loftus P; Conrad M
Int Forum Allergy Rhinol; 2023 Dec; 13(12):2172-2179. PubMed ID: 37189284
[TBL] [Abstract][Full Text] [Related]
12. Epistaxis in children and adolescents with hereditary hemorrhagic telangiectasia.
Gonzalez CD; Mcdonald J; Stevenson DA; Whitehead KJ; Petersen MG; Presson AP; Ding Q; Wilson KF
Laryngoscope; 2018 Jul; 128(7):1714-1719. PubMed ID: 29171658
[TBL] [Abstract][Full Text] [Related]
13. Epistaxis grading in Osler's disease: comparison of comprehensive scores with detailed bleeding diaries.
Parzefall T; Wolf A; Frei K; Kaider A; Riss D
Int Forum Allergy Rhinol; 2017 Mar; 7(3):293-299. PubMed ID: 28297555
[TBL] [Abstract][Full Text] [Related]
14. Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia: Effects on Epistaxis Severity Score and Quality of Life.
Baysal M; Ümit EG; Kırkızlar HO; Özdöver AC; Demir AM
Turk J Haematol; 2019 Feb; 36(1):43-47. PubMed ID: 29880465
[TBL] [Abstract][Full Text] [Related]
15. Development and performance of a hereditary hemorrhagic telangiectasia-specific quality-of-life instrument.
Kasthuri RS; Chaturvedi S; Thomas S; Vandergrift N; Bann C; Schaefer N; Clancy MS; Pyeritz R; McCrae KR
Blood Adv; 2022 Jul; 6(14):4301-4309. PubMed ID: 35877137
[TBL] [Abstract][Full Text] [Related]
16. The SF-36 health status questionnaire in assessing patients with epistaxis secondary to hereditary hemorrhagic telangiectasia.
Lennox PA; Hitchings AE; Lund VJ; Howard DJ
Am J Rhinol; 2005; 19(1):71-4. PubMed ID: 15794078
[TBL] [Abstract][Full Text] [Related]
17. Sclerotherapy Versus Cautery/Laser Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia.
Woodard TD; Yappel-Sinkko KB; Wang X; McCrae KR; Parambil JG
Laryngoscope; 2022 May; 132(5):920-925. PubMed ID: 34160081
[TBL] [Abstract][Full Text] [Related]
18. Health-Related Quality of Life Outcome Measures in Individuals With Hereditary Hemorrhagic Telangiectasia: A Scoping Review.
Gong AJ; Garg T; Khalil A; Gowda PC; Mathai SC; Rowan NR; Merlo CA; Weiss CR
Am J Rhinol Allergy; 2024 Jan; 38(1):60-76. PubMed ID: 37855028
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of two grading systems for epistaxis in hereditary haemorrhagic telangiectasia.
Jorgensen OJ; Steineger J; Bachmann-Harildstad G; Dheyauldeen S
Rhinology; 2021 Apr; 59(2):212-218. PubMed ID: 33821857
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide for Epistaxis in Patients with Hereditary Hemorrhagic Telangiectasia: A Preliminary Study.
Fang J; Chen X; Zhu B; Ye H; Zhang W; Guan J; Su K
Otolaryngol Head Neck Surg; 2017 Aug; 157(2):217-221. PubMed ID: 28418273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
